Valuation: Proteome Sciences plc

Market Cap 6.31M 8.49M 7.37M 6.87M 11.94M 807M 12.07M 81.02M 31.67M 404M 31.88M 31.18M 1.34B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 21.3M 28.64M 24.87M 23.19M 40.29M 2.72B 40.73M 273M 107M 1.36B 108M 105M 4.51B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 month+10.77%
3 months+7.14%
6 months+0.28%
Current year-28.00%
1 week 1.58
Extreme 1.578
2.1
1 month 1.3
Extreme 1.3
2.3
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
17.5
Manager TitleAgeSince
Corporate Officer/Principal - 2017-03-31
Corporate Secretary - 2017-07-31
Director TitleAgeSince
Chairman 73 2014-06-29
Director/Board Member 62 2009-12-31
Director/Board Member 71 2014-06-30
Date Insider Type Main position Quantity % Market Cap.
4/14/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/14/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/6/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-40.79%-76.08% 8.48M
-1.55%-1.69%-18.83%-2.03% 185B
-0.55%-0.78%-3.84%+2.57% 111B
-0.68%-4.16%+4.30%+65.26% 60B
-1.12%+8.02%+40.31%+53.62% 53.9B
-0.05%+2.27%-4.91%-37.18% 46.9B
+3.88%+3.78% - - 34.22B
-0.42%+16.15%+14.02%-27.75% 32.95B
+0.24%+3.49%+46.30%-7.01% 24.49B
+0.09%+1.09%+1.93%+3.03% 22.67B
Average +0.01%+2.77%+4.28%-2.84% 57.14B
Weighted average by Cap. -0.54%+0.82%-0.14%+7.36%

Financials

2024 2025
Net sales 4.89M 6.57M 5.71M 5.32M 9.24M 625M 9.34M 62.72M 24.52M 312M 24.68M 24.14M 1.04B 3.76M 5.05M 4.39M 4.09M 7.1M 480M 7.18M 48.2M 18.84M 240M 18.97M 18.55M 796M
Net income -3.41M -4.58M -3.98M -3.71M -6.44M -436M -6.51M -43.71M -17.09M -218M -17.2M -16.82M -722M -3.06M -4.12M -3.57M -3.33M -5.79M -392M -5.85M -39.28M -15.36M -196M -15.46M -15.12M -648M
Net Debt 13.39M 18.01M 15.64M 14.58M 25.33M 1.71B 25.61M 172M 67.2M 856M 67.63M 66.15M 2.84B 14.99M 20.15M 17.5M 16.32M 28.35M 1.92B 28.66M 192M 75.2M 958M 75.68M 74.03M 3.18B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
26-08-04 GBX 1.800 0.00% 502,450
26-08-03 GBX 1.800 0.00% 25,869
26-07-31 GBX 1.800 0.00% 0
26-07-30 GBX 1.800 0.00% 1,000
26-07-29 GBX 1.800 0.00% 1,880